Nasopharynx Cancer: Therapeutic Value of Chemoradiotherapy-Reference-Cited by-同舟云学术

Nasopharynx Cancer: Therapeutic Value of Chemoradiotherapy

Published:2007-10 Issue:2 Volume:69 Page:S118-S121
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

O'Sullivan Brian

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference10 articles.

1. Nasopharyngeal carcinoma;Wei;Lancet,2005

2. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients;Baujat;Int J Radiat Oncol Biol Phys,2006

3. Superiority of 5-year survival with chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer. Intergroup 0099 Phase III study: Final report;Al-Sarraf;Proc Am Soc Clin Oncol,2001

4. Final report of SQNP01—a phase III randomized trial comparing RT with chemoRT for locally advanced nasopharyngeal cancer;Wee;Int J Radiat Oncol Biol Phys,2006

5. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee;J Clin Oncol,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial;ONCOL LETT;2023

2. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway;Cell Death & Disease;2021-08

3. Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonanceimaging functional parameters and18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure;Tzu Chi Medical Journal;2021

4. A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma;Brazilian Journal of Otorhinolaryngology;2020-11

5. Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma;Reports of Practical Oncology & Radiotherapy;2020-01